Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06345976

Functional Impairment in Albinism

Status
Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Albinism is a genetic and hereditary anomaly that affects pigmentation. This pathology is characterized by a deficit in melanin production. In humans, the clinical diagnosis of albinism is based on a number of factors, including : * In the integumentary region: fair skin tone, with white hair, eyelashes and eyebrows. * Ophthalmological: reduced visual acuity, photophobia, nystagmus, transilluminated blue irises, hypopigmentation of the retina at the back of the eye with fovea plana. As treatment options begin to emerge for certain albinism-induced anomalies (including, for example, the depigmentation that causes photophobia), it is desirable to understand what these patients' complaints are, and to gather their views on the emergence of treatments targeting just one of their complaints, namely glare.

Conditions

Interventions

TypeNameDescription
OTHERquestionnaireOn-line self-questionnaire, in the form of an 18-question form, the link to which is sent by e-mail to patients with albinism who have agreed to take part in the study.

Timeline

Start date
2024-10-01
Primary completion
2025-10-01
Completion
2025-10-01
First posted
2024-04-03
Last updated
2025-02-13

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06345976. Inclusion in this directory is not an endorsement.